{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:06:04Z","timestamp":1790193964460,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>MEN1 is associated with an increased risk of developing tumors in different endocrine organs. Neuroendocrine tumors of the thymus (TNETs) are very rare but often have an aggressive nature. We evaluated patients with MEN1 and TNET in three university hospitals in Finland.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Design\/Methods<\/jats:title>\n                <jats:p>We evaluated patient records of 183 MEN1-patients from three university hospitals between the years 1985\u20132019 with TNETs. Thymus tumor specimens were classified according to the new WHO 2021 classification of TNET. We collected data on treatments and outcomes of these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were six patients (3.3%) with MEN1 and TNET. Five of them had the same common gene mutation occurring in Finland. They originated from common ancestors encompassing two pairs of brothers from sequential generations. The mean age at presentation of TNET was 44.7\u2009\u00b1\u200911.9 years. TNET was classified as atypical carcinoid (AC) in five out of six patients. One patient had a largely necrotic main tumor with very few mitoses and another nodule with 25 mitoses per 2\u2009mm<jats:sup>2<\/jats:sup>, qualifying for the 2021 WHO diagnosis of large cell neuroendocrine carcinoma (LCNEC). In our patients, the 5-year survival of the TNET patients was 62.5% and 10-year survival 31.3%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this study, TNETs were observed in one large MEN1 founder pedigree, where an anticipation-like earlier disease onset was observed in the most recent generation. TNET in MEN1 patients is an aggressive disease. The prognosis can be better by systematic screening. We also show that LCNEC can be associated with TNET in MEN1 patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-022-03099-4","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T11:22:39Z","timestamp":1655119359000},"page":"527-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1164-5640","authenticated-orcid":false,"given":"Iina","family":"Yliaska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Tokola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapani","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Kuismin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavi","family":"Ukkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna L.","family":"Koivikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Lesonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Rimpil\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuuli","family":"Felin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva","family":"Ryh\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Metso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2428-0161","authenticated-orcid":false,"given":"Camilla","family":"Schalin-J\u00e4ntti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Salmela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"3099_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.276.5311.404","volume":"276","author":"SC Chanrasekharappa","year":"1997","unstructured":"S.C. Chanrasekharappa, S. Guru, P. Manickman, S. Olufemi, F. Collins, M. Emmert-Buck, L. Debelenko, Z. Zhuang, I. Lubensky, L. Liotta et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 276, 404\u2013407 (1997). https:\/\/doi.org\/10.1126\/science.276.5311.404","journal-title":"Science"},{"key":"3099_CR2","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"R.V. Thakker, P.J. Newey, G.V. Walls, J. Bilezikian, H. Dralle, P.R. Ebeling, S. Melmed, A. Sakurai, F. Tonelli, M.I. Brandi, Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97, 2990\u20133011 (2012). https:\/\/doi.org\/10.1210\/jc2012-1230","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3099_CR3","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/1097-0142(197204)29:4%3C1075::AID-CNCR2820290457%3E3.0.CO;2-O","volume":"29","author":"J Rosai","year":"1972","unstructured":"J. Rosai, E. Higa, J. Davie,, Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis. A previously unrecognized association. Cancer 29, 1075\u20131083 (1972). https:\/\/doi.org\/10.1002\/1097-0142(197204)29:4%3C1075::AID-CNCR2820290457%3E3.0.CO;2-O","journal-title":"Cancer"},{"key":"3099_CR4","doi-asserted-by":"publisher","first-page":"S1484","DOI":"10.21037\/jtd.2017.10.83","volume":"9","author":"PL Filosso","year":"2017","unstructured":"P.L. Filosso, E. Ruffini, P. Solidoro, M. Roffinella, P.O. Lausi, P. Lyberis, A. Oliaro, F. Guerrera, Neuroendocrine tumors of the thymus. J. Thorac. Dis. 9, S1484\u2013S1490 (2017). https:\/\/doi.org\/10.21037\/jtd.2017.10.83","journal-title":"J. Thorac. Dis."},{"key":"3099_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/SLA.0b013e3181dd4ec4","volume":"251","author":"P Gaur","year":"2010","unstructured":"P. Gaur, C. Leary, J.C. Yao, Thymic neuroendocrine tumors. A SEER database analysis of 160 patients. Ann. Surg. 251, 1117\u20131121 (2010). https:\/\/doi.org\/10.1097\/SLA.0b013e3181dd4ec4","journal-title":"Ann. Surg."},{"key":"3099_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00000658-199807000-00015","volume":"228","author":"BT The","year":"1998","unstructured":"B.T. The, J. Zedenius, S. Kyt\u00f6l\u00e4, B. Skogseid, J. Trotter, H. Chopin, S. Twigg, F. Farnebo, S. Giraud, D. Cameron, B. Robinson, A. Calender, C. Larsson, P. Salmela, Thymic carcinoids in multiple endocrine neoplasia type 1. Ann. Surg. 228, 99\u2013105 (1998). https:\/\/doi.org\/10.1097\/00000658-199807000-00015","journal-title":"Ann. Surg."},{"key":"3099_CR7","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00268-009-0290-1","volume":"33","author":"P Goudet","year":"2009","unstructured":"P. Goudet, A. Murat, C. Cardot-Bauters, P. Emy, E. Baudin, H. du Boullay Chopin, Y. Chapuis, J.-L. Kraimps, J.-L. Sadoul, A. Tabarin, B. Verges, B. Carnaille, P. Niccoli-Sire, A. Costa, A. Calender, Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines). World J. Surg. 33, 1197\u20131207 (2009). https:\/\/doi.org\/10.1007\/s00268-009-0290-1","journal-title":"World J. Surg."},{"key":"3099_CR8","unstructured":"J.KC. Chan, S. Lantuejoul, A. Marx & editors. (2021) Chapter 5: Tumours of the thymus. In: WHO Classification of Tumours Editorial Board. Thoracic tumours. Lyon (France): International Agency for Research on Cancer; 2021. (WHO classification of tumours series, 5th ed.; vol. 5). https:\/\/publications.iarc.fr\/595."},{"key":"3099_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000472255","volume":"105","author":"R Jia","year":"2017","unstructured":"R. Jia, P. Sulentic, J.-M. Xu, A.B. Grossman, Thymic neuroendocrine neoplasms: biological behaviour and therapy. Neuroendocrinology 105, 105\u2013114 (2017). https:\/\/doi.org\/10.1159\/000472255","journal-title":"Neuroendocrinology"},{"key":"3099_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jtcvs.2014.08.061","volume":"149","author":"PL Filosso","year":"2015","unstructured":"P.L. Filosso, X. Yao, U. Admad, Y. Zhan, J. Huang, E. Ruffini, W. Travis, M. Lucchi, A. Rimner, A. Antonicelli, F. Guerrera, F. Detterbeck,the European Society of Thoracic Surgeons Thymic Group steering committee, Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases. J. Thorac. Cardiovasc. Surg. 149, 103\u2013109(2015). https:\/\/doi.org\/10.1016\/j.jtcvs.2014.08.061","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"3099_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00005792-199701000-00002","volume":"76","author":"BT The","year":"1997","unstructured":"B.T. The, J. McArdle, S.P. Chan, J. Menon, L. Hartley, P. Pullan, J. Ho, A. Khir, S. Wilkinson, C. Larsson, D. Cameron, J. Shepherd, Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine 76, 21\u201329 (1997). https:\/\/doi.org\/10.1097\/00005792-199701000-00002","journal-title":"Medicine"},{"key":"3099_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14017439950142046","volume":"33","author":"J Satta","year":"1999","unstructured":"J. Satta, A. Ahonen, S. Parkkila, L. Leinonen, M. Apaja-Sarkkinen, M. Lepoj\u00e4rvi, T. Juvonen, Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Scand. Cardiovasc. J. 33, 49\u201353 (1999). https:\/\/doi.org\/10.1080\/14017439950142046","journal-title":"Scand. Cardiovasc. J."},{"key":"3099_CR13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1210\/jc.2002-021314","volume":"88","author":"F Gibril","year":"2003","unstructured":"F. Gibril, Y.J. Chen, D.S. Schrump, A. Vortmeyer, Z. Zhuang, I.A. Lubensky, J.C. Reynolds, A. Louie, L.K. Entsuah, K. Huang, B. Asgharian, B.T. Jensen, Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 88, 1066\u20131081 (2003). https:\/\/doi.org\/10.1210\/jc.2002-021314","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3099_CR14","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1210\/jc.2004-1155","volume":"90","author":"P Ferolla","year":"2005","unstructured":"P. Ferolla, A. Falchetti, P. Filosso, P. Tomassetti, G. Tamburrano, N. Avenia, G. Daddi, F. Puma, R. Ribacchi, F. Santeusanio, G. Angeletti, M.L. Brandi, 2005 Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: The Italian series. J. Clin. Endocrinol. Metab. 90, 2603\u20132609 (2005). https:\/\/doi.org\/10.1210\/jc.2004-1155","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3099_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-2265.2012.04467.x","volume":"78","author":"A Sakurai","year":"2013","unstructured":"A. Sakurai, T. Imai, T. Kikumori, K. Horiuchi, T. Okamoto, S. Uchino, S. Kosugi, S. Suzuki, K. Suyama, M. Yamazaki, Sato Ai, MEN consortium of Japan. Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions. Clin. Endocrinol. 78, 248\u2013254 (2013). https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04467.x","journal-title":"Clin. Endocrinol."},{"key":"3099_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.lung.can,2012.12.001","volume":"79","author":"J Crona","year":"2013","unstructured":"J. Crona, P. Bj\u00f6rklund, S. Welin, G. Kozlovacki, K. \u00d6berg, D. Granberg, Treatment, prognostic markers and survival in thymic neuroendocrine tumours. A study from a single tertiary referral centre. Lung Cancer 79, 289\u2013293 (2013). https:\/\/doi.org\/10.1016\/j.lung.can,2012.12.001","journal-title":"Lung Cancer"},{"key":"3099_CR17","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1210\/jc.2014-1560","volume":"99","author":"JM deLaat","year":"2014","unstructured":"J.M. deLaat, C.R. Pieterman, M.F. van den Broek, J.W. Twisk, A.R. Hermus, O.M. Dekkers, W.W.de Herder, A.N.van der Horst-Schrivers, M.L.Drent, P.H.Bisschop, B.Havekes, M.R.Vriens, G.D.Valk,, Natural Course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients. J. Endocrinol. Metab. 99, 3325\u20133333 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1560","journal-title":"J. Endocrinol. Metab."},{"key":"3099_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12672-015-0228-z","volume":"6","author":"NS Ospina","year":"2015","unstructured":"N.S. Ospina, G.B. Thompson, F.C. Nichols III, S.D. Cassivi, W.F. Young Jr, Thymic and bronchial carcinoid tumors in multiple endocrine neoplasia type 1: The Mayo Clinic experience from 1977 to 2013. Horm. Cancer 6, 247\u2013253 (2015). https:\/\/doi.org\/10.1007\/s12672-015-0228-z","journal-title":"Horm. Cancer"},{"key":"3099_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12672-016-0269-y","volume":"7","author":"I Christakis","year":"2016","unstructured":"I. Christakis, W. Qiu, A.M. Silva Figueroa, S. Hyde, G.J. Cote, N.L. Busaidy, M. Williams, E. Grubbs, J.E. Lee, N.D. Perrier, Clinical features, treatments and outcomes of patients with thymic carcinoids and multiple endocrine neoplasia type 1 syndrome at MD Anderson Cancer Center. Hormones Cancer 7, 279\u2013287 (2016). https:\/\/doi.org\/10.1007\/s12672-016-0269-y","journal-title":"Hormones Cancer"},{"key":"3099_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/cen.13480","volume":"87","author":"L Ye","year":"2017","unstructured":"L. Ye, W. Wang, N.S. Ospina, L. Jiang, I. Christakis, J. Lu, Y. Zhou, Y. Zhu, Y. Cao, S. Wang, N.D. Perrier, W.F. Young Jr, G. Ning, W. Wang, Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: a single-centre study, systematic review and meta-analysis. Clin. Endocrinol. 87, 706\u2013716 (2017). https:\/\/doi.org\/10.1111\/cen.13480","journal-title":"Clin. Endocrinol."},{"key":"3099_CR21","doi-asserted-by":"publisher","first-page":"E125","DOI":"10.21037\/jtd.2018.01.127","volume":"10","author":"X Li","year":"2018","unstructured":"X. Li, M. Li, T. Shi, R. Liu, D. Ren, F. Yang, S. Wie, G. Chen, J. Chen, S. Yu, Clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients. J. Thorac. Dis. 10, E125\u2013E129 (2018). https:\/\/doi.org\/10.21037\/jtd.2018.01.127","journal-title":"J. Thorac. Dis."},{"key":"3099_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/jmg.38.3.185","volume":"38","author":"S Kyt\u00f6l\u00e4","year":"2001","unstructured":"S. Kyt\u00f6l\u00e4, A. Villablanca, T. Ebeling, B. Nord, C. Larsson, A. H\u00f6\u00f6g, F.K. Wong, M. V\u00e4lim\u00e4ki, O. Vierimaa, B.T. Teh, B.T. The, P.I. Salmela, J. Leisti, Founder effect in multiple endocrine neoplasia type 1 (MEN1) in Finland. J. Med. Genet. 38, 185\u2013189 (2001). https:\/\/doi.org\/10.1136\/jmg.38.3.185","journal-title":"J. Med. Genet."},{"key":"3099_CR23","unstructured":"D. Klimstra, G. Kl\u00f6ppel, S. La Rosa, G. Rindi, Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours Editorial Board, editor. WHO Classification of Tumours. Digestive System Tumours. 5th edition Lyon: IARC (2019). p. 16\u201319."},{"issue":"12","key":"3099_CR24","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"G. Rindi, D.S. Klimstra, B. Abedi-Ardekani, S.L. Asa, F.T. Bosman, E. Brambilla, K.J. Busam, R.R. Krijger, M. Dietel, A.K. El-Naggar, L. Fernandez-Cuesta, G. Kl\u00f6ppel, W.G. McCluggage, H. Moch, H. Ohgaki, E.A. Rakha, N.S. Reed, B.A. Rous, H. Sasano, A. Scarpa, J.-Y. Scoazec, W.D. Travis, G. Tallini, J. Trouillas, J.H. van Krieken, I.A. Cree, A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod. Pathol. 31(12), 1770\u20131786 (2018). https:\/\/doi.org\/10.1038\/s41379-018-0110-y","journal-title":"Mod. Pathol."},{"issue":"Suppl 15","key":"3099_CR25","doi-asserted-by":"publisher","first-page":"S1448","DOI":"10.21037\/jtd.2017.02.02","volume":"9","author":"H Bohnenberger","year":"2017","unstructured":"H. Bohnenberger, H. Dinter, A. K\u00f6nig, Str\u00f6bel, Neuroendocrine tumors of the thymus and mediastinum. J. Thorac. Dis. 9(Suppl 15), S1448\u2013S1457 (2017). https:\/\/doi.org\/10.21037\/jtd.2017.02.02","journal-title":"J. Thorac. Dis."},{"issue":"8","key":"3099_CR26","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.jtho.2019.04.015","volume":"14","author":"H Dinter","year":"2019","unstructured":"H. Dinter, H. Bohnenberger, J. Beck, K. Bornemann-Kolatzki, E. Schutz, S. Kuffer, L. Klein, T.J. Franks, A. Roden, A. Emmert, M. Hinterthaner, M. Marino, L. Brcic, H. Popper, C.-A. Weis, G. Pelosi, A. Marx, P.Str\u00f6bel,, Molecular classification of neuroendocrine tumors of the thymus. J. Thorac. Oncol. 14(8), 1472\u20131483 (2019). https:\/\/doi.org\/10.1016\/j.jtho.2019.04.015","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"3099_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00428-018-2307-3","volume":"472","author":"G Pelosi","year":"2018","unstructured":"G. Pelosi, F. Bianchi, E. Dama, M. Simbolo, A. Mafficini, A. Sonzogni, S. Pilotto, S. Harari, M. Papotti, M. Volante, G. Fontanini, L. Mastracci, A. Albini, E. Bria, F. Calabrese, A. Scarpa, Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm. Virchows Arch. 472(4), 567\u2013577 (2018). https:\/\/doi.org\/10.1007\/s00428-018-2307-3","journal-title":"Virchows Arch."},{"key":"3099_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.athoracsur.2012.03.062","volume":"94","author":"G Cardillo","year":"2012","unstructured":"G. Cardillo, F. Rea, M. Lucchi, M.A. Paul, S. Margaritora, F. Carleo, G. Marulli, A. Mussi, P. Granone, P. Graziano, Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. Ann. Thorac. Surg. 94, 241\u2013245 (2012). https:\/\/doi.org\/10.1016\/j.athoracsur.2012.03.062","journal-title":"Ann. Thorac. Surg."},{"issue":"7","key":"3099_CR29","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1210\/jc.2003-031513","volume":"89","author":"T Ebeling","year":"2004","unstructured":"T. Ebeling, O. Vierimaa, S. Kyt\u00f6l\u00e4, J. Leisti, P.I. Salmela, Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations. J. Clin. Endocrinol. Metab. 89(7), 3392\u20133396 (2004). https:\/\/doi.org\/10.1210\/jc.2003-031513","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3099_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/EJE-07-0195","volume":"157","author":"O Vierimaa","year":"2007","unstructured":"O. Vierimaa, T.M. Ebeling, S. Kyt\u00f6l\u00e4, R. Bloigu, E. Eloranta, J. Salmi, E. Korpi-Hy\u00f6v\u00e4lti, L. Niskanen, A. Orvola, E. Elovaara, A. Gynther, T. Sane, M. V\u00e4lim\u00e4ki, J. Ignatius, J. Leisti, P.I. Salmela, Multiple endocrine neoplasia type 1 in Northern Finland: clinical features and genotype-phenotype correlations. Eur. J. Endocrinol. 157, 285\u2013294 (2007). https:\/\/doi.org\/10.1530\/EJE-07-0195","journal-title":"Eur. J. Endocrinol."},{"key":"3099_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fendo.2019.00339","volume":"10","author":"CDC Kamilaris","year":"2019","unstructured":"C.D.C. Kamilaris, C.A. Stratakis, Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis. Front. Endocrinol. 10, 339 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00339","journal-title":"Front. Endocrinol."},{"key":"3099_CR32","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1210\/jcem.82.10.4052","volume":"82","author":"S Giraud","year":"1997","unstructured":"S. Giraud, H. Choplin, B.T. Teh, J. Lespinasse, A. Jouvet, F. Labat-Moleur, G. Lenoir, B. Hamon, P. Hamon, A. Calender, A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation. J. Clin. Endocrinol. 82, 3487\u20133492 (1997). https:\/\/doi.org\/10.1210\/jcem.82.10.4052","journal-title":"J. Clin. Endocrinol."},{"key":"3099_CR33","doi-asserted-by":"publisher","first-page":"e2491","DOI":"10.1210\/clinem\/dgaa257","volume":"105","author":"MFM van den Broek","year":"2020","unstructured":"M.F.M. van den Broek, B.P.M. van Nesselrooij, C.R.C. Pieterman, A.A. Verrijn Stuart, A.C. van de Ven, W.W. de Herder, O.M. Dekkers, M.L. Drent, B. Havekes, M.N. Kerstens, P.H. Bisschop, G.D. Valk, Clues for genetic anticipation in multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 105, e2491\u2013e2500 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa257","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3099_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/jmg.31.3.261","volume":"31","author":"BT The","year":"1994","unstructured":"B.T. The, N.K. Hayward, M.K. Walters, J.J. Sherpherd, S. Wilkinson, M. Nordenskj\u00f6ld, C. Larsson, Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1. J. Med. Genet. 31, 261\u2013262 (1994). https:\/\/doi.org\/10.1136\/jmg.31.3.261","journal-title":"J. Med. Genet."},{"key":"3099_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-01659-7","volume":"20","author":"H Zheng","year":"2020","unstructured":"H. Zheng, S. Zhou, W. Tang, Q. Wang, X. Zhang, X. Jin, Y. Yuan, J. Fu, p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1; a case report. BMC Neurol. 20, 76 (2020). https:\/\/doi.org\/10.1186\/s12883-020-01659-7","journal-title":"BMC Neurol."},{"key":"3099_CR36","doi-asserted-by":"publisher","first-page":"L15","DOI":"10.1530\/ERC-21-0226","volume":"28","author":"A Mandl","year":"2021","unstructured":"A. Mandl, J.M. Welch, G. Kapoor, V.I. Parekh, D.S. Schrump, R.T. Ripley, M.F. Walter, J. Del Rivero, S. Jha, W.F. Simonds, R.T. Jensen, L.S. Weinsterin, J.E. Blau, S.K. Agarwal, Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus. Endocr. Relat. Cancer 28, L15\u2013L19 (2021). https:\/\/doi.org\/10.1530\/ERC-21-0226","journal-title":"Endocr. Relat. Cancer"},{"key":"3099_CR37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1530\/EJE-15-0691","volume":"175","author":"J Thevenon","year":"2015","unstructured":"J. Thevenon, A. Bourredjem, L. Faivre, C. Cardot-Bauters, A. Calander, M. le Bras, S. Giraud, P. Niccoli, M.F. Odou, F. Borson-Chazot, A. Barlier, C. Lombard-Bohas, E. Clauser, A. Tbarin, E. Pasman, O. Chabre, E. Castermans, P. Ruszniewski, J. Bertherat, B. Delemr, S. Christin-Maitre, A. Beckers, I. Guilhem, V. Rohmer, B. Goichot, P. Caron, E. Baudin, P. Chanson, L. Groussin, H. Du Boullay, G. Weryha, P. Lecomte, F. Schillo, H. Bihan, F. Archambeaud, V. Kerlan, N. Bourcigaux, J.M. Kuhn, B. Verges, M. Rodier, M. Renard, J.L. Sadoul, C. Binquet, P. Goudet, Unraveling the intrafamilial correlations and heritability of tumor types in MEN1; a Group d\u2019etude des Tumeurs Endocrines study. Eur. J. Endocrinol. 175, 819\u2013826 (2015). https:\/\/doi.org\/10.1530\/EJE-15-0691","journal-title":"Eur. J. Endocrinol."},{"key":"3099_CR38","doi-asserted-by":"publisher","first-page":"T119","DOI":"10.1530\/ERC-17-0199","volume":"24","author":"SK Agarwall","year":"2017","unstructured":"S.K. Agarwall, The future: genetic advances in MEN1 therapeutic approaches and management strategies. Endocr. Relat. Cancer 24, T119\u2013T134 (2017). https:\/\/doi.org\/10.1530\/ERC-17-0199","journal-title":"Endocr. Relat. Cancer"},{"key":"3099_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","volume":"34","author":"P Goudet","year":"2010","unstructured":"P. Goudet, A. Murat, C. Binquet, C. Cardot-Bauters, A. Costa, P. Ruszniewski, P. Niccoli, F. Menegaux, G. Chabrier, F. Borson-Chazot, A. Tabarin, P. Bouchard, B. Delemer, A. Beckers, C. Bonithon-K, Risk factors and caused of death in MEN1 disease. A GTE (Groupe d\u2019Etude des Tumeurs Endocrines) cohort study among 758 patients. World J. Surg. 34, 249\u2013255 (2010). https:\/\/doi.org\/10.1007\/s00268-009-0290-1","journal-title":"World J. Surg."},{"key":"3099_CR40","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/gcc.22183","volume":"53","author":"P Str\u00f6bel","year":"2014","unstructured":"P. Str\u00f6bel, A. Zettl, K. Shilo, W.-Y. Chuang, A.G. Nicholson, Y. Matsuno, A. Gal, R.H. Laeng, P. Engel, C. Capella, M. Marino, J.K.-C. Chan, A. Rosenwald, W. Travis, T.J. Franks, D. Ellenberger, I.-M. Schaefer, A. Marx, Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic study. Genes Chromosom. Cancer 53, 738\u2013749 (2014). https:\/\/doi.org\/10.1002\/gcc.22183","journal-title":"Genes Chromosom. Cancer"},{"key":"3099_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fendo.2018.00533","volume":"9","author":"JM de Laat","year":"2018","unstructured":"J.M. de Laat, R.S. van Leeuwaarde, G.D. Valk, The importance of an early and accurate MEN1 diagnosis. Front. Endocrinol. 9, 533 (2018). https:\/\/doi.org\/10.3389\/fendo.2018.00533","journal-title":"Front. Endocrinol."},{"key":"3099_CR42","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jc.2014-3659","volume":"100","author":"P Goudet","year":"2015","unstructured":"P. Goudet, A. Dalac, M. Le Bras, C. Cardot-Bauters, P. Niccoli, N. Levy-Bohbot, H. du Boullay, X. Bertagna, P. Ruszniewski, F. Borson-Chazot, B. Verges, J.L. Sadoul, F. Menegaux, A. Tabarin, J.M. Kuhn, P. d\u2019Anella, O. Chabre, S. Christin-Maitre, G. Cadiot, C. Binquet, B. Delemer, MEN1 disease occurring before 21 years old: A 160-patients cohort study from the Groupe d\u2019etude de Tumeurs Endocrines. J. Clin. Endocrinol. Metab. 100, 1568\u20131577 (2015). https:\/\/doi.org\/10.1210\/jc.2014-3659","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3099_CR43","doi-asserted-by":"publisher","first-page":"T209","DOI":"10.1530\/ERC-17-0231","volume":"24","author":"J Manoharan","year":"2017","unstructured":"J. Manoharan, M.B. Albers, D.K. Bartsch, The future: diagnostic and imaging advances in MEN1 therapeutic approaches and management strategies. Endocr. Relat. Cancer 24, T209\u2013T225 (2017). https:\/\/doi.org\/10.1530\/ERC-17-0231","journal-title":"Endocr. Relat. Cancer"},{"key":"3099_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1530\/EC-17-0006","volume":"6","author":"RT Casey","year":"2017","unstructured":"R.T. Casey, D. Saunders, B.G. Challis, D. Pitfield, H. Cheow, A. Shaw, H.L. Simpson, Radiological surveillance in multiple endocrine neoplasia type 1: a double-edged sword? Endocr. Connect 6, 151\u2013158 (2017). https:\/\/doi.org\/10.1530\/EC-17-0006","journal-title":"Endocr. Connect"},{"key":"3099_CR45","doi-asserted-by":"publisher","unstructured":"M.L Koivikko, T.M.L. Ebeling, M.J. M\u00e4kinen, J. Lepp\u00e4luoto, A. Raappana, P. Ahtiainen, P. Salmela, Acromegaly caused by a GHRH-producing pancreatic tumor- a rare manifestation of MEN1-syndrome. (2022) https:\/\/doi.org\/10.1530\/EDM-21-0079","DOI":"10.1530\/EDM-21-0079"},{"key":"3099_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2265.2002.01535.x","volume":"57","author":"E Boix","year":"2002","unstructured":"E. Boix, A. Pico, R. Pinedo, I. Aranda, K. Kovacs, Ectopic growth hormone-realeasing hormone secretion by thmymic carcinoid tumour. Clin. Endocrinol 57, 131\u2013134 (2002). https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01535.x","journal-title":"Clin. Endocrinol"},{"key":"3099_CR47","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/1759-7714.12868","volume":"9","author":"J Wen","year":"2018","unstructured":"J. Wen, J. Chen, D. Chen, D. Liu, X. Yu, L. Huang, J. Cao, J. Zhang, Y. Gu, M. Fan, Y. Chen, Evaluation of the prognostic value of surgery and postoperative radiotherapy for patients with thymic neuroendocrine tumors; a propensity-matched study based on the SEER database. Thorac. Ancer. 9, 1603\u20131613 (2018). https:\/\/doi.org\/10.1111\/1759-7714.12868","journal-title":"Thorac. Ancer."},{"key":"3099_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4103\/1450-1147.203068","volume":"16","author":"C Naik","year":"2020","unstructured":"C. Naik, S. Basu, Peptide receptor radionuclide therapy with 177 Lu-DOTATATE for metastatic neuroendocrine tumor occurring in association with multiple endocrine neoplasia type 1 and Cushing\u2019s syndrome. World J. Nucl. Med 16, 126\u2013132 (2020). https:\/\/doi.org\/10.4103\/1450-1147.203068","journal-title":"World J. Nucl. Med"},{"key":"3099_CR49","doi-asserted-by":"publisher","first-page":"vii120","DOI":"10.1093\/annonc\/mds267","volume":"23","author":"K \u00d6berg","year":"2012","unstructured":"K. \u00d6berg, P. Hellman, P. Ferolla, H. Papotti; on behalf of the ESMO Guidelines Working Group, Neuroendocrine bronchial and thymic tumors: ESMO clinical practice guidelines for diagnosis, treatment and floow-up. Ann. Oncol. 23, vii120\u2013vii123 (2012). https:\/\/doi.org\/10.1093\/annonc\/mds267","journal-title":"Ann. Oncol."},{"key":"3099_CR50","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","volume":"26","author":"ME Caplin","year":"2015","unstructured":"M.E. Caplin, E. Baudin, P. Ferolla, P. Filosso, M. Garcia-Yuste, E. Lim, K. Oberg, G. Pelosi, A. Perren, R.E. Rossi et al. 2015 Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann. Oncol. 26, 1604\u20131620 (2015). https:\/\/doi.org\/10.1093\/annonc\/mdv041","journal-title":"Ann. Oncol."},{"key":"3099_CR51","doi-asserted-by":"publisher","first-page":"S1491","DOI":"10.21037\/jtd.2017.08.18","volume":"9","author":"N Girard","year":"2017","unstructured":"N. Girard, Neuroendocrine tumors of the thymus: the oncologist point of view. J. Thorac. Dis. 9, S1491\u2013S1500 (2017). https:\/\/doi.org\/10.21037\/jtd.2017.08.18","journal-title":"J. Thorac. Dis."},{"key":"3099_CR52","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/S1470-2045(17)30681-2","volume":"18","author":"P Ferolla","year":"2017","unstructured":"P. Ferolla, M.P. Brizzi, T. Meyer, W. Mansoor, J. Mazieres, C.D. Cao, H. Lena, A. Berruti, V. Damiano, W. Buikhuisen, H. Goenbeak, C. Lombard-Bohas, C. Grohe, V. Minotti, M. Tiseo, J. De Gastro, N. Reed, G. Gislimberti, N. Singh, M. Stankovic, K. \u00d6berg, E. Baudin, Effifacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomized, phase 2 trial. Lancet Oncol. 18, 1652\u20131664 (2017). https:\/\/doi.org\/10.1016\/S1470-2045(17)30681-2","journal-title":"Lancet Oncol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03099-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T15:31:41Z","timestamp":1660750301000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03099-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["3099"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03099-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"28 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}